Back to market news

EU drug agency approved Moderna’s vaccine

EU drug agency approved Moderna’s vaccine

EU drug agency approved Moderna’s vaccine

The European Medicines Agency (EMA) has recommended Moderna as the second vaccine against COVID-19 for conditional authorization in the European Union today. For EU countries to start using a substance from an American company after the Pfizer and BioNTech vaccine, its distribution has yet to be approved by the European Commission. 

Emer Cooke, the agency's head of conditional recommendations commented: "This vaccine gives us another tool to overcome the current crisis." According to her, the EMA will continue to monitor the safety and efficacy data provided by the manufacturer. The agency recommended that the vaccine be given to patients over 18 years of age.

The EU announced that it will exercise the option for 100 million additional doses of vaccine from the Pfizer-BioNTech. It is also negotiating an agreement that could double that number, people familiar with the talks said on Tuesday.

Moderna shares are up by more than 3% before the opening of US stock exchanges.

Performance of Moderna’s shares (Tradingview.com)

Read more

Are you ready for big banks Q4 earnings?

Are you ready for big banks Q4 earnings?

Fourth-quarter earnings season kicks off on Thursday with better -than – expected results from the investment firm BlackRock (NYSE: BLK). The banking giants JPMorgan Chase (NYSE: JPM), Citigroup (NYSE: C) and Wells Fargo (NYSE: WFC) will release its fourth-quarter results on Friday before the bell.

NIO, the Chinese version of Tesla soaring to new heights

NIO, the Chinese version of Tesla soaring to new heights

On Monday, the Chinese electric automaker NIO Inc – ADR (NYSE: NIO) shares rose 8% higher and hit new all-time-high following the company launched mass production of new electric car on Saturday. NIO also announced a collaboration with Nvidia Corp, the latest electric vehicle ET7 will use NVIDIA Drive Orin SoC for AI-assisted driving.